HOME >> BIOLOGY >> NEWS
Anthrax: 'A soil bug gone bad'

Rockville, MD Scientists at The Institute for Genomic Research (TIGR) and collaborators have deciphered the genome of the notorious Ames strain of the bacterium that causes anthrax, Bacillus anthracis. It is the first anthrax strain to be completely sequenced and analyzed.

That genome analysis, published in the May 1, 2003, issue of Nature, found only small differences in gene content that distinguish the deadly anthrax bacillus from the common soil bacterium, Bacillus cereus, that thrives in gardens across the globe.

There may be no more than about 150 significant differences in the 5,000-plus genes in the chromosomes of those related bacterial species, says TIGR researcher Tim Read, the first author of the Nature letter. Other differences are found on small circular strands of DNA, called plasmids, which are key to the virulence of B. anthracis.

Those natural genomic differences including the plasmid-encoded genes that make the anthrax bacterium toxic and virulent in attacking human and animal hosts have made B. anthracis a potent pathogen. Over the last seven decades, the anthrax bacillus was developed and weaponized as a biowarfare/bioterror agent by several national programs, from Japan in the 1930s to Iraq in the 1980s.

TIGRs President, Claire M. Fraser, who supervised the anthrax genome project, says that the DNA sequence provides an invaluable tool for researchers who are seeking to develop new drugs or vaccines against anthrax, as well as for others who are investigating better ways to detect or trace the pathogen.

Deciphering the anthrax genome is important to a wide range of biomedical and biodefense research, says Fraser. The genome sequence will benefit research projects to find targets for new drugs and vaccines as well as to improve anthrax detection and diagnosis. Since the B. anthracis sequencing project was started in 1999, TIGR had been posting preliminary anthrax genome data already used by rese
'"/>

Contact: Robert Koenig
rkoenig@tigr.org
301-838-5880
The Institute for Genomic Research
30-Apr-2003


Page: 1 2 3 4

Related biology news :

1. Cleaner water, more efficient electricity among UH chemical research
2. Alcohol-use and depression among pregnant and postpartum women
3. Parents are top influence on soft-drink consumption among kids
4. University of Pittsburgh medical center among first to implant heart assist device
5. Professor and student among tops in technology at UH
6. UCSD study shows how we perceive world depends on precise division of labor among cells in brain
7. Chronic respiratory symptoms prevalent among Alaska natives
8. Specifying alcohol-related brain-damage among heavy social drinkers
9. Researchers identify unifying code among diverse classes of natural antibiotics
10. Marsupial among model organisms next in line for sequencing
11. Mastectomy dramatically reduces breast cancer risk among women with BRCA1/2 mutations

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2020)... ... July 21, 2020 , ... ... innovation in technology and compliance, announces a new solution to manage regulated workloads ... every layer of their technology stack complies with FDA and global regulations. USDM's ...
(Date:7/4/2020)... ... July 03, 2020 , ... ... earn outstanding recognition and multiple awards for not only the products and treatments ... SoME® Skincare and Vivace® Microneedle RF. All the brands built by ABM have ...
(Date:6/28/2020)... Switzerland (PRWEB) , ... June ... ... provider of enterprise software solutions for biopharmaceutical R&D, today announced that it ... company developing innovative, full-length multispecific antibodies (Multiclonics®), to support their translational and ...
Breaking Biology News(10 mins):
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed Tech , ... Solutions, in a one hour live webinar on Thursday, August 13, 2020 ... for drugs and medical devices. Specifically, for medical devices, the NMPA has departments dealing ...
(Date:7/18/2020)... MILWAUKEE (PRWEB) , ... July 16, 2020 , ... “We ... at Third Wave Bioactives. “It’s the only technology of its kind on the market ... flavor of onions with the protective capacity of traditional cultured ingredients, creating a natural ...
(Date:7/18/2020)... ... , ... dicentra , a leading Contract Research Organization ... pleased to announce that Charles Galea has joined its clinical trials division as ... accomplished and results-driven sales executive with over 10 years of expertise in business ...
(Date:7/10/2020)... ... July 09, 2020 , ... PathSensors ... (MIT) has expanded the company’s exclusive license to include clinical applications for ... diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and ...
Breaking Biology Technology:
Cached News: